Shares of Conmed CNMD moved lower in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 1114.29% year over year to $0.71, which beat the estimate of $0.62.
Revenue of $255,161,000 rose by 61.71% from the same period last year, which beat the estimate of $248,310,000.
Outlook
The upcoming fiscal year's EPS expected to be between $3.15 and $3.25.
The upcoming fiscal year's revenue expected to be between $1,015,000,000 and $1,035,000,000.
How To Listen To The Conference Call
Date: Jul 28, 2021
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/6szhyndp
Technicals
52-week high: $146.95
Company's 52-week low was at $69.60
Price action over last quarter: down 2.10%
Company Profile
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
